The effects of Zinc, vitamin D supplementation and co-supplementation of them versus placebo on lipid profile in overweight and obese subjects
Phase 3
- Conditions
- Obesity.Obesity due to excess calories
- Registration Number
- IRCT20180910040997N1
- Lead Sponsor
- arestan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 140
Inclusion Criteria
age between 20 to 60 years old
BMI greater than 27
willing to participate
weight stable in 3 last months
Exclusion Criteria
having a history of coronary artery disease; acute or chronic renal failure;acute or chronic hepatic failure; presence of any chronic inflammatory and autoimmune disease; and any known malignancy
use of vitamin and mineral supplement in 3 last months
smoking
Use of any type of drug including anti-inflammatory drugs (NSAIDs, salicylates, steroids), aminoglycoside antibiotics, blood pressure control drugs and blood glucose
professional athlete
having a special diet for any reason prescribed by the clinic dietitian
A person's desire to have a weight loss diet
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Serum level of lipid profile including Triglyceride, HDL, LDL, TC. Timepoint: Before and 12 weeks after intervention. Method of measurement: Serum concentration of lipid profile (TG, TC, LDL, HDL).
- Secondary Outcome Measures
Name Time Method